For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2013 (2)
- (-) 2005 (3)
- (-) 2003 (3)
- (-) 1996 (3)
- (-) 1988 (2)
- (-) 1976 (2)
- 2022 (1)
- 2020 (1)
- 2017 (1)
- 2016 (2)
- 2015 (2)
- 2014 (1)
- 2012 (1)
- 2010 (1)
- 2009 (1)
- 2008 (3)
- 2007 (2)
- 2006 (1)
- 2004 (2)
- 2002 (2)
- 2001 (2)
- 2000 (1)
- 1999 (3)
- 1998 (2)
- 1997 (2)
- 1994 (2)
- 1992 (2)
- 1991 (1)
- 1990 (1)
- 1989 (1)
- 1987 (1)
- 1986 (1)
- 1985 (3)
- 1983 (2)
- 1979 (5)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
1996
1988
For advances in protein structure and enzyme mechanisms by use of affinity labeling and site-directed mutagenesis.
For fundamental contributions to many areas of theoretical solid-state physics that directly relate to experimental programs, including the electronic structure and magnetism of transition and rare-earth metals, metal-electrolyte interfaces, superconductivity, and physical properties of heavy fermion, mixed valent, and fractal materials
1976
For contributions to the development of new concepts and advanced systems for power generation and conversion, through innovative designs of nuclear reactors for aircraft propulsion and space auxiliary power and concepts for thermonuclear fusion reactor power plants
For research extending the theoretical description of direct nuclear reactions and nuclear structure, as one of the first theorists to implement the much more refined and detailed treatment of experimental data made possible by computers